You are here

Europe: Big losses for stocks as Caterpillar, China disappoint

SL_cat_290119_16.jpg
European shares slid on Monday as optimism about the end of a US government shutdown faded and growth worries reared their head again.

[LONDON] European shares slid on Monday as optimism about the end of a US government shutdown faded and growth worries reared their head again.

The pan-European Stoxx 600 lost 0.97 per cent, its biggest fall since Jan 3, as a profit warning from Caterpillar cemented investors' pessimistic mood after data showed the second consecutive drop in Chinese industrial profits in December.

The double whammy of negative industrial news drove investors to dump risky assets, with banks, tech, autos and oil among the worst-performing.

Investors have remained highly sceptical of European stocks despite a relatively robust rally year-to-date.

sentifi.com

Market voices on:

"Medium-term threats to European unity, the European economy's still-anaemic growth and its dependence on trade do make us cautious toward European risk assets," said Blackrock global chief investment strategist Richard Turnill in a note.

A profit warning from Caterpillar, the U.S. heavy machinery and vehicle maker seen as a bellwether for global economic activity, drove European stocks further down and abruptly ended an early rally in mining shares.

Italian heavy machinery maker CNH Industrial tumbled 3.8 per cent, the biggest faller on the FTSE MIB.

Reflecting investors' fears about global growth, financials were the biggest drag on the Stoxx 600, with HSBC, Santander, Allianz, and BNP Paribas down 0.8 to 1.8 per cent.

Oil majors BP, Royal Dutch Shell, and Total tumbled as Brent crude futures suffered their biggest one-day drop in a month on evidence of yet more growth in US crude supply.

The oil sector fell 1.9 per cent, its biggest loss in five weeks.

In single-stock moves, German biotech firm MorphoSys led losers with a 7.7 per cent fall after a US court ruled three Morphosys patents invalid, in a lawsuit against Janssen Biotech and Genmab.

"MorphoSys' management commented that it is disappointed and will consider all of its options (including a potential appeal)," wrote Deutsche Bank analysts, cutting their target price on the stock to 125 euros from 130.

Genmab shares were up 2.5 per cent.

Another big loser was Alstom, which fell 3.6 per cent after the French group and Germany's Siemens offered new concessions to try to satisfy the European Commission's antitrust concerns over their plan to merge.

Despite the last-minute concessions, their efforts to create a European rail champion could yet be scuppered.

Shares in Norwegian aluminium producer Norsk Hydro dropped 4.3 per cent as aluminium prices fell following the United States' decision to lift sanctions on the world's second largest aluminium producer United Company Rusal.

French engineering consulting firm Altran Technologies lost 3.1 per cent after it announced it had been the target of a cyber attack that hit operations in some European countries.

REUTERS